THE METHOD OF DETERMINING THE DEVELOPMENT RISK OF THE TERMINAL STATE OF THE IMMUNODEFICIENCY FOR THE HIV-INFECTED PATIENTS

摘要

Invention relates to medicine, particularly to molecular genetics and infection diseases, may be used in the discovery of human genome mutation to determine the risk of the development of the state of immunodeficiency in HIV infected patients.The method, wherein to determine the said risk dots mutation, in particular, second exon dot mutation in codon 9, 11, 13, 28, 30, 38, 47, and 82, in the second exon of the HLA-DRB1*01:01 gene are established, is introduced.